We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

CAR-T Cells Combined With Peptide Specific Dendritic Cell in Relapsed/Refractory Leukemia

This study is currently recruiting participants.
Verified September 2017 by Zhujiang Hospital
Sponsor:
ClinicalTrials.gov Identifier:
NCT03291444
First Posted: September 22, 2017
Last Update Posted: September 22, 2017
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
Collaborators:
Shenzhen Geno-Immune Medical Institute
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Information provided by (Responsible Party):
Zhujiang Hospital
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: March 1, 2022
  Estimated Primary Completion Date: March 1, 2021 (Final data collection date for primary outcome measure)